France Dry Powdered Inhaler Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2025

France dry powdered inhaler market is anticipated to grow at a substantial rate of around 3.5% during the forecast period. Well-developed healthcare infrastructure and medical device industry coupled with the significant prevalence of asthma and COPD in the country are influencing factors for the market growth. As per French government agency, Business France, the country ranked as 4th globally and second in Europe for medical device and technology industry. There are about 1,300 to 1,350 companies in French device manufacturer that generated a revenue of around $32 billion in 2017. The country is generating about $9.5 billion in 2017 by export of medical devices. The medical device market is providing employment to about 85,000 people in the country. This provides a significant base for the growth of medical Dry Powdered Inhaler market over the forecast period.

To Request a Sample of our Report on France Dry Powdered Inhaler Market:  https://www.omrglobal.com/request-sample/france-dry-powdered-inhaler-market

France dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators dry powdered inhalers are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

(Get 15% Discount on Buying this Report)

A full Report of France Dry Powdered Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/france-dry-powdered-inhaler-market

France Dry Powdered Inhaler Market Segmentation

 By Type

·        Preventive Inhaler
·        Reliever Inhaler
·        Long Acting Bronchodilators Inhaler

By Application

·        Asthma

·        Chronic Obstructive Pulmonary Disease (COPD)

By End-User

·        Homecare

·        Hospitals and Clinics

Company Profiles

·        3M Co.

·        Acorda Therapeutics, Inc.

·        Adamis Pharmaceuticals Corp.

·        Adherium Ltd.

·        Air Liquide S.A.

·        AstraZeneca PLC

·        Bespak

·        Boehringer Ingelheim International GmbH

·        Chiesi Farmaceutici S.P.A.

·        GlaxoSmithKline PLC

·        H&T Presspart Manufacturing Ltd.

·        Koninklijke Philips N.V.

·        Novartis AG

·        Omron Healthcare Inc.

·        ResMed Corp.

·        Pulmatrix Inc.

·        Savara, Inc.

·        Teicos Pharma Ltd.

·        Teva Pharmaceuticals Industries Ltd.

·        Vitalograph Ltd.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404